Apellis Pharmaceuticals, Inc. SEC Filings http://investors.apellis.com/ Apellis Pharmaceuticals, Inc. SEC Filings en 8-K: Report of unscheduled material events or corporate event http://investors.apellis.com/sec-filings/sec-filing/8-k/0001193125-19-178796 APELLIS PHARMACEUTICALS, INC. Fri, 21 Jun 2019 16:19:44 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7791 8-K: Report of unscheduled material events or corporate event http://investors.apellis.com/sec-filings/sec-filing/8-k/0001193125-19-168507 APELLIS PHARMACEUTICALS, INC. Mon, 10 Jun 2019 07:33:44 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7781 SC 13G/A: An amendment to the SC 13G filing http://investors.apellis.com/sec-filings/sec-filing/sc-13ga/0001104659-19-031738 APELLIS PHARMACEUTICALS, INC. Fri, 24 May 2019 13:48:54 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7761 10-Q: Quarterly report which provides a continuing view of a company's financial position http://investors.apellis.com/sec-filings/sec-filing/10-q/0001564590-19-016638 APELLIS PHARMACEUTICALS, INC. Tue, 07 May 2019 17:31:18 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7726 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") http://investors.apellis.com/sec-filings/sec-filing/def-14a/0001193125-19-127347 APELLIS PHARMACEUTICALS, INC. Tue, 30 Apr 2019 08:06:13 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7721 DEFA14A: Additional proxy soliciting materials - definitive http://investors.apellis.com/sec-filings/sec-filing/defa14a/0001193125-19-127354 APELLIS PHARMACEUTICALS, INC. Tue, 30 Apr 2019 08:06:12 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7716 3: Initial filing by director officer or owner of more than ten percent. http://investors.apellis.com/sec-filings/sec-filing/3/0000899243-19-010651 APELLIS PHARMACEUTICALS, INC. Mon, 15 Apr 2019 17:39:56 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7711 3: Initial filing by director officer or owner of more than ten percent. http://investors.apellis.com/sec-filings/sec-filing/3/0000899243-19-010649 APELLIS PHARMACEUTICALS, INC. Mon, 15 Apr 2019 17:37:56 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7706 3: Initial filing by director officer or owner of more than ten percent. http://investors.apellis.com/sec-filings/sec-filing/3/0000899243-19-010648 APELLIS PHARMACEUTICALS, INC. Mon, 15 Apr 2019 17:33:56 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7701 8-K: Report of unscheduled material events or corporate event http://investors.apellis.com/sec-filings/sec-filing/8-k/0001193125-19-104692 APELLIS PHARMACEUTICALS, INC. Fri, 12 Apr 2019 10:06:40 -0400 Apellis Pharmaceuticals, Inc. SEC Filings 7696